Improved outcomes in indigent patients with ketosis-prone diabetes: effect of a dedicated diabetes treatment unit

Endocr Pract. 2003 Jan-Feb;9(1):26-32. doi: 10.4158/EP.9.1.26.

Abstract

Objective: To investigate whether a specialized intervention program could improve diabetes-related health outcomes in indigent patients with type 1 diabetes who were prone to occurrence of diabetic ketoacidosis (DKA).

Methods: Patients with type 1 diabetes mellitus admitted because of DKA during a 24-month period were invited to receive outpatient care in a diabetes treatment unit (DTU). We compared DKA-related readmission rates, change in hemoglobin A1c (HbA1c) values, and diabetes-related medical costs in patients who participated in the DTU program (+DTU) and in those who did not (-DTU).

Results: During the study period, 115 patients underwent assessment. Of this overall group, 57 patients (49.6%) consented to participate in the DTU program, and 58 (50.4%) did not. After the follow-up period (median duration, 657 days), the following significant improvements were observed in the +DTU group (in comparison with the -DTU group): lower frequency of readmission for DKA (16% versus 43%; P = 0.001), lower number of readmissions for DKA per patient (0.22 +/- 0.6 versus 1.17 +/- 2.2 [mean +/- standard deviation]; P = 0.003), lower HbA1c level (10.4 +/- 2.3% versus 13.5 +/- 2.3%; P<0.0001), and lower cost of diabetes-related medical care (3,427.20 US dollars +/- 6,275.60 versus 10,119.10 US dollars +/- 19,688.10; P = 0.01). Multivariate analysis revealed that participation in the DTU program was the only factor associated with a significantly decreased risk of DKA-related readmission.

Conclusion: Low-cost intervention by a dedicated outpatient DTU resulted in significant decreases in DKA-associated readmissions, in HbA1c values, and in costs of diabetes care in a multiethnic, indigent, ketosis-prone patient population.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Ambulatory Care / economics
  • Diabetes Mellitus, Type 1 / economics
  • Diabetes Mellitus, Type 1 / therapy*
  • Diabetes Mellitus, Type 2 / economics
  • Diabetes Mellitus, Type 2 / therapy
  • Female
  • Hospital Units / economics
  • Hospital Units / organization & administration*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Male
  • Multivariate Analysis
  • Patient Readmission / economics
  • Patient Readmission / statistics & numerical data
  • Proportional Hazards Models
  • Treatment Outcome
  • Uncompensated Care* / economics

Substances

  • Hypoglycemic Agents
  • Insulin